Le Lézard
Classified in: Health, Science and technology

R3 Stem Cell Now Offering Regenerative Therapy for Post Stroke Patients


LAS VEGAS, July 18, 2018 /PRNewswire-PRWeb/ -- R3 Stem Cell is now offering effective regenerative medicine therapies for post stroke patients. The procedures are performed by Double Board Certified physicians at the R3 Stem Cell Center of Excellence in Las Vegas.

Each year close to 800,000 individuals in the US suffer a stroke, which amounts to to one every 40 seconds. Traditional thinking has been that patients have approximately eighteen months to achieve maximal recovery after a stroke, and then are left with residual deficits.

Stem cell therapy for stroke is showing to be effective for helping patients recover well after the eighteen month time frame. Excellent studies such as the recent one out of Stanford showed that patients achieved excellent improvements in motor function even years afterwards.

In addition, the stem cell therapies for stroke have been shown to be safe for patients, with no significant complications. R3 Stem Cell offers a patient concierge service, which entails a complimentary phone or in person consultation along with a medical record review.

The biologic material used is FDA regulated, with no embryonic stem cells being used. R3 Stem Cell has an industry leading safety record.

Overall, R3 Stem Cell has successfully treated over 10,000 patients with regenerative procedures at over 30 Centers nationwide. Treatments are offered for arthritis, autoimmune conditions, organ failure, neurodegenerative conditions, neuropathy and more.

Call (844) GET-STEM to get set up for the complimentary consultation with R3's Board Certified providers to see about being a candidate.

 

SOURCE R3 Stem Cell


These press releases may also interest you

at 09:10
StatLab Medical Products ("StatLab"), a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition of Scientific Device Laboratory ("SDL"), a Chicago-based manufacturer of printed diagnostic...

at 09:10
Global metalworking fluid, grease, and lubricating oil manufacturers, notably those seeking new, more sustainable lubricants using renewable base oils/high-quality additives for the automotive and electric vehicle (EV) industries, can anticipate new...

at 09:05
LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Chief Executive Officer, President and member...

at 09:05
Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Jade Cusick as its new Chief Commercial Officer and member of the Ontada leadership...

at 09:05
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver broadly accessible, off-the-shelf natural killer (NK) cell-based therapies to patients suffering from devastating autoimmune diseases and cancers, today announced the...

at 09:05
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and...



News published on and distributed by: